ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

NCAB Ok’s Funding First Three Years Of Diet Trial

December 7, 1990

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010

ORI Whistle-Blower Proposal Too Rigid, Biologists Say.

February 2, 2001

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

Healthcare Utilization Figures More Than Biology In Disparity

April 30, 2010